Full text is available at the source.
Abstract
A non-viral lipid nanoparticle strategy successfully delivered full-length EYS plasmid DNA (~11.6 kb) for retinal gene therapy.
- Gene augmentation for inherited retinal diseases is limited by the size of viral vectors, making large genes difficult to deliver.
- The lipid nanoparticle formulation using ionizable lipid KC2 and DOPC demonstrated high encapsulation efficiency and effective gene expression.
- Functional delivery of EYS was confirmed in retinal pigment epithelial cell cultures through imaging and gene expression analysis.
- In ex vivo bovine retinal explants, EYS mRNA expression was detected after simulating subretinal injections, indicating successful delivery.
- This approach is the first reported instance of delivering a large (>10 kbp) gene relevant to inherited retinal diseases using lipid nanoparticles.
Simplified